Profil
Michael W.
Yurkowsky is the founder of Deverra Therapeutics, Inc. Current positions include Chief Executive Officer & Independent Director at Innoveren Scientific, Inc. since 2021, Chief Executive Officer at Immuni-T, Inc., Owner at YP Holdings LLC (Florida), and President at Jantibody LLC.
Former positions include Director at Vicapsys Life Sciences, Inc. from 2019 to 2022, Vice President-Investments at Wachovia Securities LLC in 2003, and Owner at Trenchant Asset Management Ltd.
Postes actifs de Michael Yurkowsky
| Sociétés | Poste | Début |
|---|---|---|
| INNOVEREN SCIENTIFIC INC. | Directeur Général | 06/12/2021 |
YP Holdings LLC (Florida) | Corporate Officer/Principal | - |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Develops off-the-shelf allogeneic cellular immunotherapies | Directeur Général | - |
Immuni-T, Inc. | Directeur Général | - |
Jantibody LLC
Jantibody LLC Pharmaceuticals: MajorHealth Technology Provides cancer treatment drugs | President | - |
Anciens postes connus de Michael Yurkowsky
| Sociétés | Poste | Fin |
|---|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 22/09/2022 |
Wachovia Securities LLC
Wachovia Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/08/2003 |
Trenchant Asset Management Ltd. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Wachovia Securities LLC
Wachovia Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Vicapsys Life Sciences, Inc.
Vicapsys Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops transplantation therapies and encapsulated product candidates | Health Technology |
Innoveren Scientific, Inc.
Innoveren Scientific, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers treatments for patients with chronic respiratory and pulmonary disorders | Health Technology |
Trenchant Asset Management Ltd. | |
YP Holdings LLC (Florida) | |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Develops off-the-shelf allogeneic cellular immunotherapies | Health Technology |
Immuni-T, Inc. | |
Jantibody LLC
Jantibody LLC Pharmaceuticals: MajorHealth Technology Provides cancer treatment drugs | Health Technology |
















